-transparent.png){kind=logo}
Expression of mRNAs coding for the ACTH secretagogues corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) was examined in the hypothalamic paraventricular nucleus (PVN) of rats bearing hippocampal lesions. Either total hippocampectomy (HPX) or extirpation of the dorsal hippocampus (DHPX) precipitated a 4-fold increase in CRF mRNA expression relative to sham-operated controls (SHAM), as determined by semiquantitative in situ hybridization histochemistry. AVP mRNA was localized to individual parvocellular neurons of the medial parvocellular division of the PVN in only the HPX and DHPX groups, consistent with enhanced production of AVP message in this neuronal population subsequent to hippocampal damage. HPX did not affect AVP mRNA content in magnocellular divisions of PVN. Plasma beta-endorphin levels were significantly elevated in the HPX and DHPX groups relative to SHAM animals, indicating a chronic increase in release of proopiomelanocortin peptides from the anterior pituitary gland in response to hippocampal lesion. Circulating corticosterone levels were elevated in HPX rats as well. To control for effects of lesion size and location, additional animals received large ablations of cerebral cortex or cerebellum. In neither case was CRF or AVP mRNA significantly altered in the PVN. The results suggest that the hippocampus exercises a tonic inhibitory role on ACTH secretagogue production in neuroendocrine neurons promoting ACTH release.
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
February 2003,
Current opinion in pharmacology,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
May 1988,
Pharmacological research communications,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
January 1996,
Critical reviews in neurobiology,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
September 1996,
Trends in endocrinology and metabolism: TEM,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
December 2005,
Progress in neuro-psychopharmacology & biological psychiatry,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
May 2006,
Psychoneuroendocrinology,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
June 1995,
Journal of neuroendocrinology,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
May 2009,
Immunology and allergy clinics of North America,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
June 2005,
Annals of the New York Academy of Sciences,
J P Herman, and
M K Schäfer, and
E A Young, and
R Thompson, and
J Douglass, and
H Akil, and
S J Watson
December 1999,
Bailliere's best practice & research. Clinical endocrinology & metabolism,
